Skip to main content

Table 2 Baseline characteristics of the study population (n = 2611) according to tertiles of HOMA-IR

From: Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study

HOMA-IR, tertiles

Tertile 1

Tertile 2

Tertile 3

HOMA-IR

1.1 ± 0.4

2.3 ± 0.4

4.9 ± 2.3

(Range)

0.4-1.7

1.7-3.0

3.0-23.3

 

n = 872

n = 870

n = 869

Age (years)

59.4 ± 10.5

60.0 ± 10.4

59.4 ± 10.4

Male gender, n (%)

593 (68)

611 (70)

658 (76)

Body mass index (kg/m2)

24.7 ± 3.1

26.7 ± 3.4

28.9 ± 4.2

Abdominal adipose tissue (cm)

7.6 ± 2.0

8.7 ± 2.2

10.1 ± 2.5

Current smoking, n (%)

288 (33)

245 (28)

251 (29)

Creatinin clearance MDRD (ml/min/1.73 m2)

79.0 ± 16.8

75.4 ± 16.4

74.0 ± 18.3

Medication

   

Lipid-lowering agents, n (%)

624 (72)

671 (77)

709 (82)

Anti-platelet agents, n (%)

689 (79)

723 (83)

724 (83)

Blood pressure-lowering agents, n (%)

588 (67)

654 (75)

751 (86)

Location of manifest arterial disease

   

Cerebrovascular disease, n (%)

263 (30)

261 (30)

206 (24)

Coronary heart disease, n (%)

509 (58)

540 (62)

614 (71)

Peripheral arterial disease, n (%)

138 (16)

127 (15)

133 (16)

Abdominal aortic aneurysm, n (%)

56 (6)

64 (7)

44 (5)

Atherosclerotic burden

   

CIMT(mm)

0.88 ± 0.24

0.89 ± 0.25

0.89 ± 0.22

Albumin/creatinin ratio > 3.0 mg/mmol, n (%)

120 (14)

120 (14)

135 (16)

Metabolic syndrome components

   

Metabolic syndrome (ATPIII), n (%)

148 (17)

232 (37)

582 (67)

Waist circumference (cm)

87.6 ± 10.6

94.0 ± 10.5

100.5 ± 11.8

Blood pressure systolic (mmHg)

138 ± 20

141 ± 21

142 ± 21

Blood pressure diastolic (mmHg)

81 ± 11

83 ± 11

84 ± 11

Fasting glucose (mmol/l)

5.4 ± 0.5

5.7 ± 0.6

6.1 ± 0.8

Triglycerides (mmol/l)

1.0 (0.8-1.4)

1.2 (0.9-1.7)

1.1 (0.9-1.3)

HDL-cholesterol (mmol/l)

1.4 ± 0.4

1.3 ± 0.4

1.1 ± 0.3

LDL-cholesterol (mmol/l)

2.7 ± 0.9

2.7 ± 1.0

2.6 ± 0.9

hs-CRP (mg/l)

1.4 (0.6-3.2)

1.6 (0.8-3.7)

2.1 (1.0-4.3)

Fasting insulin (mIU/l)

4.8 ± 1.6

9.1 ± 1.5

17.9 ± 7.8

QUICKI

0.32 ± 0.05

0.26 ± 0.01

0.22 ± 0.02